Your browser doesn't support javascript.
loading
Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test.
Pu, Yiyi; Weng, Youhong; Wu, Yahan; Gao, Fei; Zheng, Xiaojun; Xiong, Xianqin; Lv, Hangjun; Kong, Qingming.
Afiliación
  • Pu Y; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
  • Weng Y; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Wu Y; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Gao F; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Zheng X; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Xiong X; Department of Research and Development, Hangzhou AllTest Biotech Co., Ltd, Hangzhou, China.
  • Lv H; Institute of Parasitic Diseases, Hangzhou Medical College, Hangzhou, China.
  • Kong Q; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.
Front Cell Infect Microbiol ; 12: 915751, 2022.
Article en En | MEDLINE | ID: mdl-35719335
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza